Skip to main content
OpenTrials

Clinical trial condition

Metastatic Castration-resistant Prostate Cancer

Explore clinical trials studying Metastatic Castration-resistant Prostate Cancer. Study availability and eligibility vary by location and protocol.

141 public trials 56 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Castration-resistant Prostate Cancer trial results

Recruiting

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

NCT06067841

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations
  • Stanford Cancer Center Palo Alto, California, United States
  • Florida Cancer Specialists Sarasota Drug Development Unit Sarasota, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

NCT05519449

Conditions
Castration Resistant Prostatic Cancer, Genital Diseases, Genital Diseases, Male, +11 more
Locations
  • University of Alabama at Birmingham Hospital Birmingham, Alabama, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Department of Medicine Los Angeles, California, United States
View all 35 locations
View Trial Details
Recruiting

Study of Re-treatment With [177Lu]Lu-PSMA in Men With Metastatic Castration Resistance Prostate Cancer

NCT06866938

Conditions
Metastatic Castration-resistant Prostate Cancer
Locations
  • Médecine Nucléaire, Institut Bergonié Bordeaux, France
  • Oncologie Médicale, CHU Brest-Hôpital Morvan Brest, France
  • Hôpital Louis Pradel, Hospices Civils de Lyon Bron, France
  • Oncologie Médicale, Centre François Baclesse Caen, France
View all 16 locations
View Trial Details
Recruiting

A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study

NCT06531499

Conditions
Metastatic Castration-resistant Prostate Cancer
Locations
  • University of California LA Los Angeles, California, United States
  • Stanford University Palo Alto, California, United States
  • Mayo Clinic Rochester Rochester, Minnesota, United States
  • Wash U School of Medicine St Louis, Missouri, United States
View all 21 locations
View Trial Details
Recruiting

A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients

NCT06155084

Conditions
Metastatic Castration-resistant Prostate Cancer
Locations
  • The Second Hospital Of Anhui Medical University Hefei, Anhui, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
View all 27 locations
View Trial Details

Related conditions